Apos Recognized by NICE & NHS England’s MedTech Funding Mandate Policy as a Cost-Saving Solution in Knee Osteoarthritis

July 8, 2024

AposHealth, a leader in non-invasive knee osteoarthritis treatment with its flagship Apos®, has achieved significant recognition, underscoring its commitment to innovative, clinically effective, and cost-saving solutions.

Key accomplishments include being selected for support under NHS England’s MedTech Funding Mandate policy, receiving a NICE recommendation, and being recognized by the UK Department of Health & Social Care as a disruptive medical technology and incremental in its implementation

NICE Endorses Apos® for Knee Osteoarthritis Treatment:

Following an independent review, the National Institute for Health and Care Excellence (NICE) has recommended the Apos® foot-worn medical device for treating knee osteoarthritis1.

This endorsement is based on rigorous clinical research demonstrating the device’s effectiveness in reducing pain and improving function4,5. The NICE recommendation validates the clinical efficacy of Apos® and positions it as an effective option for patients with knee osteoarthritis that non-surgical care has not worked well enough and who meet the criteria for surgery but do not want it.

Apos® Selected by NHS England’s MedTech Funding Mandate policy for 2024/25:

Apos® has been selected to receive support under the MedTech Funding Mandate (MTFM) policy from 2024/25. This selection by NHS England is a milestone for AposHealth® and highlights its commitment to advancing patient care and innovation. The MTFM policy, a commitment of the NHS Long Term Plan, aims to accelerate the adoption of effective and cost-saving medical technologies faster and more equitably.

As a result, Apos® will become more accessible to NHS patients. Following a positive recommendation from NICE, Apos® was selected for its effectiveness, cost-saving benefits within three years, and affordability to the NHS.

UK Department of Health & Social Care Recognizes Apos® as a Case Study for Disruptive Medical Technologies:

The UK’s Department of Health & Social Care has recognized Apos® as a prime example of a disruptive medical technology that offers substantial cost savings and patient benefits through incremental implementation3. This recognition underscores the device’s ability to deliver exceptional patient outcomes and material cost savings without complex integration into existing healthcare systems.

A Transformative Solution for Knee Osteoarthritis:

Apos® is a non-invasive, non-drug, personalized biomechanical footworn medical device designed to shift pressure away from painful areas in the knee and retrain the body’s walking patterns. Clinical studies have shown significant pain relief, improvement in function and quality of life4, delay or avoidance of knee surgery5, 6, and reduction of healthcare costs7.

“Adding Apos® to the knee OA care pathway is an important step that will enable many patients to receive a non-surgical intervention to treat their knee pain as an alternative option to surgery. Apos®’s recent achievements highlight the potential to transform patient care and deliver substantial cost savings to patients and healthcare systems”, says Cliff Bleustein, MD, MBA, President and CEO of AposHealth.

About AposHealth® :

We at AposHealth® are passionate about revolutionizing the treatment of musculoskeletal conditions by simply addressing peoples’ gait to help alleviate pain and help them move and live better. Our flagship solution, Apos®, is CE-marked, NICE-recommended, and FDA-cleared; it is designed to effectively relieve knee pain caused by osteoarthritis. Additionally, Apos® is FDA-registered and evidence-based for relieving chronic lower back and hip pain.

With over 150,000 patients treated and over 70 peer-reviewed publications supporting the science behind Apos® and its clinical effect, this program—consisting of gait analysis, personalized foot-worn medical device, and customized treatment plan—has helped patients worldwide move, live, and thrive.

Apos® is available in the US and is covered by many insurance plans, as well as across the NHS through the NHS supply chain. For more information, visit aposhealth.com or aposhealth.co.uk.

References:

1. https://www.nice.org.uk/guidance/mtg76

2. https://www.england.nhs.uk/aac/what-we-do/how-can-the-aac-help-me/the-medtech-funding-mandate/

3. https://www.gov.uk/government/publications/medical-technology-innovation-classification-framework/medical-technology-innovation-classification-framework

4.Reichenbach A, Felson DT, Hincapi CA, Heldner S, Butikofer L, Lenz A, da Costa BR, Bonel HM, Jones RK, Hawker GA, Juni P. Effect of Biomechanical Footwear on Knee Pain in People With Knee Osteoarthritis. The BIOTOK Randomized Clinical Trial. JAMA 2020;323(18):1802-1812. 

5.Andrew Greene, Christopher Miles. Surgery avoidance rates among total knee replacement candidates following a non-invasive biomechanical intervention: A retrospective cohort study, Journal of Orthopaedic Experience & Innovation. October 2022. https://doi.org/10.60118/001c.37664

6.Shema-Shiratzky S, Mor A, Elbaz A. Non-Invasive Biomechanical Intervention Leads to Low Rates of Total Knee Replacement and Reduced Utilization of Healthcare Resources among Older Adults with Chronic Knee Pain: A 5-Year Follow-Up study. Journal of Musculoskeletal Disorders and Treatment 2023, 9(1):121. DOI: 10.23937/2572-3243.1510121.

7.Josh Mark, Shirley Shema-Shiratzky, Joel Sommer, Tim Nolan, Ganit Segal. Reduction in Healthcare Resource Utilization Following Treatment With a Home-Based Footworn Device in Patients With Knee Osteoarthritis: A Retrospective Claims Analysis. J Health Econ Outcomes Res. 2024 May 16;11(1):134-140. doi: 10.36469/001c.117155.eCollection 2024. https://pubmed.ncbi.nlm.nih.gov/38765914/

See if Apos® is right for you

Book a consultation to find out if you're covered.

Step 1 of 3

Ready to finally find pain relief? Check your coverage

By sharing your contact information, a team of experts and you can evaluate and discuss how you may be eligible for Apos®. After that, we can start your journey supported by a team of Apos® clinicians — experts who will guide your care from day one.

In case your healthcare coverage is not listed, please choose “Other.”

By providing your phone and email, you agree to calls, SMS, and email. Unsubscribe via email link or reply STOP to SMS.

Step 2 of 3

What type of pain do you have?

(Select all that apply)

Apos® shifts pressure, activates key muscles, and helps retrain your movement - so every step supports healing. Understanding where you feel the pain allows us to advise you on the best course of action.

Step 3 of 3

What parts of your life are affected by your pain?

(Select all that apply)

Clinical research has shown that Apos® improves daily function by 60% on average. Having a fuller picture of how your life is impacted by the pain enables us to determine which approach is best for you.

You may qualify

Great news — you may qualify for Apos® treatment

By helping with your pain and daily life, Apos® may be a fit for you.

Did you know that, based on our data, most of our patients with your insurance type pay less than $50 out of pocket (for the personalized medical device and treatment program valued at over $4,500)?

Book your free consultation below to confirm your coverage and check eligibility.

How would you like to connect?

    Watch an Apos® patient story

    Privacy choices

    Manage your cookie & privacy preferences

    Choose what AposHealth® can use beyond what's needed to run the site. Necessary items keep booking, video, and security working and can't be turned off. Your choice is stored on this browser until you change it.

    Necessary Always on

    Keeps the site working: the booking widget, video player, quiz progress, and security. These only run when you use them directly and never track you across other websites.

    Helps us understand overall site traffic and performance. Not used for advertising, remarketing, or building an audience profile.

    Do Not Sell or Share My Personal Information. Covers targeted advertising and any sharing of personal data for cross-context behavioral advertising. AposHealth® does not currently run ad campaigns or sell personal information — this stays off unless you turn it on.